Form 4 for BSX Boston Scientific
Accepted 2022-12-12 00:00:00 ET · period of report 2022-12-09 · accession 0001225208-22-012558 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-12 | 2022-12-09 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale+OE | $46.15 | -41.0K | 99.6K | -29% | -$1.89M |
| D | 2022-12-12 | 2022-12-09 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $13.08 | +29.6K | 140.6K | +27% | +$387.2K |
| D | 2022-12-12 | 2022-12-09 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $0.00 | -29.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-09 | S | D | 41,032 | $46.15 | 99,559 | D | — | — | (F2) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $45.97 to $46.26, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2022-12-09 | M | A | 29,599 | $13.08 | 140,591 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-12-09 | M | D | 29,599 | $0.00 | 0 | D | $13.08 · — to 2024-02-24 | 29,599 Common Stock | (F3) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant. |